meta-analysis | Q815382 |
systematic review | Q1504425 |
review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Tracey J. Woodruff | Q79276473 |
Daniel A. Axelrad | Q50419939 | ||
P2093 | author name string | Karen A Robinson | |
Dylan S Atchley | |||
Erica Koustas | |||
Juleen Lam | |||
Patrice Sutton | |||
Paula I Johnson | |||
Saunak Sen | |||
P2860 | cites work | Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha | Q23914416 |
Industry sponsorship and research outcome | Q24202591 | ||
The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water | Q24623988 | ||
Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) | Q24632957 | ||
Endocrine disrupting properties of perfluorooctanoic acid | Q24633469 | ||
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort | Q24680484 | ||
Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
Meta-analysis in clinical trials | Q27860779 | ||
Sources, fate and transport of perfluorocarboxylates | Q28293419 | ||
Environmental chemicals in pregnant women in the United States: NHANES 2003-2004 | Q28389338 | ||
GRADE guidelines: 3. Rating the quality of evidence | Q29547891 | ||
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography | Q29615697 | ||
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) | Q29619791 | ||
Births: final data for 2010. | Q30833846 | ||
An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences | Q84069114 | ||
How to obtain the P value from a confidence interval | Q84579508 | ||
Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures | Q85173906 | ||
The GRADE approach and Bradford Hill's criteria for causation | Q85197280 | ||
Perfluorinated compounds in umbilical cord blood and adverse birth outcomes | Q31083691 | ||
Meta-analysis of skewed data: combining results reported on log-transformed or raw scales | Q33370319 | ||
Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals | Q34207902 | ||
The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes | Q34275302 | ||
The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth | Q34275308 | ||
The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. | Q34275367 | ||
The developmental toxicity of perfluoroalkyl acids and their derivatives | Q34331477 | ||
The toxicology of perfluorooctanoate | Q34343282 | ||
Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. | Q34799750 | ||
Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome | Q34998270 | ||
Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community | Q35874820 | ||
Environmental and toxicity effects of perfluoroalkylated substances | Q35887227 | ||
Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study | Q35941792 | ||
Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study | Q36023451 | ||
Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley | Q36229096 | ||
Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls | Q36379797 | ||
Emerging endocrine disrupters: perfluoroalkylated substances | Q37100285 | ||
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. | Q37149764 | ||
Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives | Q37476192 | ||
GRADE guidelines: 9. Rating up the quality of evidence | Q37908614 | ||
Polyfluorinated compounds: past, present, and future | Q37922167 | ||
Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature | Q38007735 | ||
Guest editorial: biomarkers of perfluorinated chemicals and birth weight | Q42714063 | ||
Pre- and postnatal exposure to perfluorinated compounds (PFCs). | Q42932834 | ||
Maternal exposure to perfluorinated acids and fetal growth | Q43253111 | ||
Forest Plot Viewer: a new graphing tool | Q43502632 | ||
Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors | Q43505312 | ||
Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. | Q43745356 | ||
Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit | Q45068572 | ||
Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. | Q46012667 | ||
Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds | Q46198292 | ||
Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort | Q46442964 | ||
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q56528982 | ||
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones | Q58765976 | ||
The effect of prenatal perfluorinated chemicals exposures on pediatric atopy | Q61851028 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hydrocarbon | Q43648 |
carboxylic acid | Q134856 | ||
systematic review | Q1504425 | ||
lipid | Q11367 | ||
evidence-based medicine | Q691640 | ||
maternal exposure | Q67002819 | ||
physiological phenomenon | Q66615932 | ||
P1104 | number of pages | 12 | |
P304 | page(s) | 1028-1039 | |
P577 | publication date | 2014-10-01 | |
P1433 | published in | Environmental Health Perspectives | Q1345904 |
P1476 | title | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth | |
P478 | volume | 122 |
Q28554273 | A Systematic Review and Meta-Analysis of Multiple Airborne Pollutants and Autism Spectrum Disorder |
Q92816502 | A Systematic Review of the Epidemiologic Literature Assessing Health Outcomes in Populations Living near Oil and Natural Gas Operations: Study Quality and Future Recommendations |
Q30234472 | A primer on systematic reviews in toxicology. |
Q28384100 | A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals |
Q92705241 | Adaptation of the Systematic Review Framework to the Assessment of Toxicological Test Methods: Challenges and Lessons Learned with the Zebrafish Embryotoxicity Test |
Q28384535 | Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan |
Q45949327 | Association between Exposure to p,p'-DDT and Its Metabolite p,p'-DDE with Obesity: Integrated Systematic Review and Meta-Analysis. |
Q51763587 | Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular aging during pregnancy and postpartum. |
Q99556536 | Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco |
Q36350881 | Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK) |
Q52563098 | Automated screening of research studies for systematic reviews using study characteristics. |
Q88601254 | Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review |
Q94948784 | Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health |
Q37077698 | Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008). |
Q36225641 | Cumulative Chemical Exposures During Pregnancy and Early Development |
Q33898370 | Cumulative effects of prenatal-exposure to exogenous chemicals and psychosocial stress on fetal growth: Systematic-review of the human and animal evidence. |
Q49843499 | Cumulative exposure to environmental pollutants during early pregnancy and reduced fetal growth: the Project Viva cohort |
Q46019996 | Developmental PBDE Exposure and IQ/ADHD in Childhood: A Systematic Review and Meta-analysis. |
Q28383132 | EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals |
Q29247894 | Early Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and Neurodevelopment |
Q47789399 | Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? |
Q99623638 | Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects |
Q93000711 | Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women |
Q60949067 | Endocrine Disruptors and Autism Spectrum Disorder in Pregnancy: A Review and Evaluation of the Quality of the Epidemiological Evidence |
Q62091446 | Endocrine disruptors and neonatal anthropometry, NICHD Fetal Growth Studies - Singletons |
Q38890087 | Endocrine-Disrupting Chemicals and Reproductive Health. |
Q89861740 | Endocrine-Disrupting Chemicals in Human Fetal Growth |
Q91347645 | Environmental contaminants and child's growth |
Q89779976 | Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX) |
Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
Q38266411 | Fetal growth and maternal glomerular filtration rate: a systematic review. |
Q36993990 | GRADE: Assessing the quality of evidence in environmental and occupational health |
Q42617846 | Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study |
Q102152315 | Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life |
Q42375164 | Hazardous waste and health impact: a systematic review of the scientific literature. |
Q92531127 | Human zoonotic tuberculosis and livestock exposure in low- and middle-income countries: A systematic review identifying challenges in laboratory diagnosis |
Q59189011 | Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes |
Q40533182 | Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia |
Q89247444 | In Response: Bias in the science that supports environmental assessments--A perspective from regulatory assessment |
Q50079208 | Incorporation of fetal and child PFOA dosimetry in the derivation of health-based toxicity values |
Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
Q33564787 | Maternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight |
Q36513368 | Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain |
Q38667467 | Maternal serum PFOA concentration and DNA methylation in cord blood: A pilot study |
Q64125808 | Maternal serum concentrations of perfluoroalkyl substances and birth size in British boys |
Q91961959 | Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight |
Q92949725 | Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study |
Q42352810 | O'Connor et al. systematic review regarding animal feeding operations and public health: critical flaws may compromise conclusions |
Q50130740 | Obesity Pathogenesis: An Endocrine Society Scientific Statement |
Q100444139 | Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research |
Q40137662 | Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study |
Q92714774 | Perfluorooctanoic acid exposure during pregnancy alters the apoptosis of uterine cells in pregnant mice |
Q92154674 | Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure |
Q38690520 | Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations |
Q47732834 | Potential Developmental and Reproductive Impacts of Triclocarban: A Scoping Review |
Q97526919 | Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function |
Q57144626 | Prenatal Exposure to Perfluoroalkyl Substances: Infant Birth Weight and Early Life Growth |
Q64136246 | Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study |
Q36396103 | Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study |
Q93160224 | Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota |
Q57846605 | Response of chlorophyll a to total nitrogen and total phosphorus concentrations in lotic ecosystems: a systematic review protocol |
Q38690032 | Systematic comparison of study quality criteria |
Q42924301 | Systematic reviews: perhaps "the answer to policy makers' prayers"? |
Q60924352 | Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study |
Q37580534 | The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study |
Q37041883 | The Emergence of Systematic Review in Toxicology |
Q34275367 | The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. |
Q34275308 | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth |
Q34275302 | The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes |
Q42924277 | The Navigation Guide: systematic review for the environmental health sciences |
Q99575838 | The effect of occupational exposure to welding fumes on trachea, bronchus and lung cancer: A protocol for a systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury |
Q28079859 | Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals |
Q36601073 | Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population |
Q77796922 | WHO/ILO work-related burden of disease and injury: protocol for systematic reviews of exposure to occupational ergonomic risk factors and of the effect of exposure to occupational ergonomic risk factors on osteoarthritis of hip or knee and ... |